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Introduction 
 
Each of the United Kingdom’s five National Health Service (NHS) homeopathic hospitals has reported 
clinical outcomes data from a wide range of medical complaints.1, , ,  2 3 4 [add ref for GHH data] In each 
unit, positive outcome has been reported by about 70% of follow-up patients overall, indicating the need 
for research initiatives to establish the positive effects of the homeopathic intervention in particular 
diagnoses.5, 6 From the perspective of quality assurance, on the other hand, these outcomes studies have 
each been carried out without an explicit aim of knowing and sustaining the optimum clinical outcomes 
that can reasonably be expected in patients with given medical complaints. Moreover, the earlier studies 
have each used different methods and outcome scoring techniques, without an overarching objective to 
unify approaches to clinical data collection across all hospitals. 
 
This work represents the beginning of a programme of quality assurance and development across all five 
homeopathic hospitals. It has the medium-term aim of setting standards for homeopathic practice 
outcomes in patients with medical complaints commonly treated in the outpatient setting of each unit. 
Here we report our findings from an initial pilot data collection study within this quality development 
process. It represents the first collaborative effort by the five individual units. 
 
Aims 
1.  To pilot the collection of clinical data in the homeopathic hospital outpatient setting, using ORIDL 
(Outcome Related to Impact on Daily Living) as outcome measure; to record patient-assessed change 
(in Main Complaint, MC, and/or in Well-being, WB) since the first homeopathic appointment. 
 
2. By obtaining a 4-week cross section of clinical data at all five homeopathic hospitals in the UK, to 
catalogue a representative range of medical complaints that doctors treat using homeopathy in 
hospital outpatients, and thus identify the complaints most frequently treated at a national level. 
 
3.  To present a cross section of patient-reported outcome scores by visit number for each of the most 
frequently treated medical complaints. 
 
4. To begin to explore methods of standards setting for homeopathic practice outcome in each of the 
most frequently treated medical complaints in outpatients treated at the homeopathic hospitals. 
 
 
 
                                                
Methods 
 
The study design and methods were agreed by all the authors, many of whom are members of the Faculty 
of Homeopathy’s Clinical Audit Sub-Committee. A total of 50 medical practitioners contributed to the 
data collection – see Acknowledgements. 
 
An Access database (or Excel spreadsheet – see below) enabled the recording of all consecutive 
homeopathy appointments, under the following headings:  
• Date of first homeopathic appointment for current medical complaint (day, month, year) 
• Appointment number (1[=first appointment] to 6; >6 [non-specified]) 
• Age of patient 
• Sex of patient 
• Main Complaint being treated using a ‘drop-down’ menuh of 263 Complaints (using ICD-10 
nomenclature)i 
• Whether other main medical complaint/s (Yes/No)j 
• Patient-assessed change in the Main Complaint (MC) at follow-up (FU), using ORIDL 
• Patient-assessed change in overall Well-being (WB) at FU, using ORIDL 
• Whether also receiving other Complementary or Alternative Medicine (CAM) therapy for this 
complaint at this hospital (Yes/No). 
 
Data were collected at Homeopathy clinics only i.e. not Acupuncture, Autogenic Training, etc. Lifestyle, 
dietary (including vitamin supplements) or other “homeopathic” advice was not categorised as “other 
CAM therapy”, but regarded as part of normal homeopathic therapy. “Main complaint” was the doctor's 
opinion as to the nature of the principal health concern at the time of initial referral (e.g. from the GP 
letter or his/her own notes). 
 
 
h The Excel version contained a “pick-list” of the same medical complaints, whose entries could be 
copied and pasted into an Appointments page. 
i If a patient presented with a complaint that was not in the drop-down menu, the new term was typed into 
the free-text field (or directly into the column “Main Complaint” in Excel). 
j Patients with complex individual predicaments, or who had more than one nameable main complaint, 
were recorded under a single “Main Complaint”, together with an entry “Yes” in the field labelled 
“Whether other main complaint/s”. 
 
 
The outcome measure used to assess change was ORIDL. The ORIDL instrument (formerly referred to as 
the Glasgow Homoeopathic Hospital Outcome Score, GHHOS) has been developed to measure a 
patient's views of the outcome of their care by asking about change, and relating this to impact on daily 
living. In a preliminary validation of ORIDL there was significant agreement between patient outcomes 
assessed by the ORIDL and the EQOL transition scale, the MYMOP, and the PEI-outcome instrument, 
suggesting that the ORIDL may be a valid and sensitive tool for measuring change in relation to impact 
on life.7 Detailed instructions on use of ORIDL were provided to each participating doctor in each 
hospital. These instructions are shown in Appendix A. Doctors recorded data during the patient 
appointment. All patient data were anonymous at source; individual doctor identity was not recorded. In 
each hospital, all data files were collected together to create a single hospital record (in Excel format). 
The file was then sent by e-mail to the study co-ordinator (RTM) and thence to the data analyst (ESB). 
 
Methods of data analysis 
The raw data from each hospital were reformatted into a standardised Excel spreadsheet, which allowed 
ease of use for filtering and locating any incomplete or erroneous data entries. Each column of data was 
filtered for missing values, which were addressed either by correction or exclusion. Terminology for non-
listed medical complaints was reconciled using ICD-10 coding nomenclature. Through this procedure, 23 
extra options were added to the original list, bringing the final number of listed complaints to 286. All 
eczemas (allergic contact [9.2% of eczema patients], atopic [45.4%], seborrhoeic [3.7%], unspecified 
[41.7%]), except varicose eczema (4 cases), were reconciled under the single heading “eczema”. 
 
The spreadsheet was then consolidated into a master file containing all data from all hospitals, and 
arranged into a number of different pivot table layouts for the various analytical approaches. The extra 
columns “Frequency” and “WB + MC Scores” were added to facilitate the pivot table analysis. Data 
from the patient sample were presented as national and single hospital statistics. In addition, the most 
frequently reported medical complaints and their treatment outcomes were each tabulated or graphed by 
number of FU visit. For this purpose, the two ORIDL scores per patient were averaged (range, -4 to +4, 
increments of 0.5); we have termed this aggregate the ORIDL Profile Score (OPS). Sub-set analysis was 
carried out on patients who had other main medical complaints (co-morbidity) or who were also being 
treated for their main complaint with other CAM therapy in the same hospital. 
 
 
 
After the study was completed, practitioners were sent a brief questionnaire, designed to gauge their 
personal experience of using the database or spreadsheet and their opinions of the value they attributed to 
the data the study produced. 
 
Results 
 
Data collection took place during the four 5-day periods from 5th to 30th March 2007; no individual 
patient was expected to receive more than a single appointment within that time. The Access database 
was used at three of the hospitals, and the Excel version at the other two. Electronic format was used in 
all hospitals except one, where some practitioners used a hard-copy version of the spreadsheet, 
necessitating manual data transcription into Excel. There was a low incidence of essential missing data. 
Only two records were excluded altogether: one was due to missing “Complaint” data; the other was a 
second appointment for a single patient during the 4-week period of data collection (outside the scope of 
the study). There were 53 missing or invalid dates recorded, of which 22 were corrected and 31 were 
stated as “missing data”. These were only excluded when they were essential to a particular analysis 
(such as “average time to appointment”). There was one missing value in each of “Gender”, “ORIDL-
WB” and “Whether other main medical complaint”, which were excluded and flagged in any analysis 
involving them specifically. 
 
Patient demographics and medical complaints treated 
There were 1797 patient visits overall, 195 being first appointments and 1602 FUs. The totals per 
hospital are shown in Table 1, which also shows the distributions of patient visits for up to or greater 
than the sixth appointment. Size of clinical service and the proportion of patients who attended more than 
6 visits varied considerably between units. The precise number of visits greater than 6 was not recorded. 
Overall, 45% of patients had attended more than 6 homeopathic appointments, the highest frequency of 
appointments being patients on their second visit (Figure 1 [?redo as relative frequency]). The 
relationship between visit number and time since first homeopathic appointment per hospital is shown in 
Table 2, where inter-hospital differences in timing of FU appointments are evident, especially for 
appointments after number 3. Patient age profile overall showed a bimodal distribution, with a main peak 
at 49 years and a secondary peak at 6 years (Figure 2). Male: female ratio was 1: 3.5. 
 
A wide range of complaints was reported: 235 in total over all the hospitals. The top 35 complaints (all 
those seen in 10 or more patients) are listed in Table 3: the most frequently treated were (1) eczema, (2) 
 
 
chronic fatigue, (3) osteoarthritis, (4) menopausal disorder, and (5) depression. Overall, 47.8% of patients 
reported important co-morbidity; 13.2% of patients were receiving another CAM therapy at the hospital 
for their main medical complaint. The proportion of patients with important co-morbidity was higher in 
those seen after visit 6 (56.9%) compared with those seen before visit 6 (41.9%; P=000). The complaints 
that were most frequently treated also varied with appointment number: after visit 6, the highest 
frequency was chronic fatigue, followed by... 
 
Homeopathic practice outcomes 
There was close correspondence overall between ORIDL-MC and ORIDL-WB scores. ORIDL-MC and 
ORIDL-WB were strongly correlated over their entire range (rS = 0.71). 
 
Table 4 gives mean (s.d.) values of OPS by visit number for all FU patients taken together, as well as for 
each of the 10 most frequently treated medical complaints. It is clear that, in general, patients seen at later 
appointments reported ever more positive outcomes than those at earlier FU visits; those who had been 
seen more than 6 times had mean OPS=1.98, slightly higher than the mean OPS at appointments 4, 5 and 
6. The apparent magnitude and degree of change of patient-reported improvement differed considerably 
among the top 10 complaints: patients with eczema typically reported greater degree of improvement, 
and at earlier appointments, compared with CFS patients, for example. Equivalent complaint-specific 
information per hospital was also derived (data not shown) and communicated directly to each. 
 
Participating doctors’ views 
Completed questionnaires were received from 19 practitioners. All but one found the database/ 
spreadsheet easy to use and the instructions helpful; only one participant had not used such software 
previously. A number of constructive suggestions were offered for improvement in the next phase of the 
study. More than half the practitioners formally used the ORIDL question sequence, and all but two felt it 
was straightforward to score a patient’s stated outcome. All participants found it worth having recorded 
data in this way. All but three derived useful factual information about their own hospital’s practice data 
and two of those practitioners had not seen their hospital’s data report at that time. The following are 
examples of quotes from participating clinicians: 
 
The database was easy to use, except the entry of first appointment dates. 
I think we need to include other conventional interventions since last visit. 
 
 
Not all of the patients understood the outcome questions. Older patients had difficulties 
understanding, which created time pressures. It usually was easy to score, but not always. 
 
Discussion 
 
A database/spreadsheet for the collection of demographic and clinical outcomes data in the homeopathic 
hospital outpatient setting was successfully piloted, using ORIDL to record patient-assessed change in 
MC and WB since the first homeopathic appointment. The ORIDL Profile Score (OPS) provides a useful 
index of change, reflecting strongly correlated MC and WB scores across all medical complaints. 
Information has been obtained on patient demographics and on the most frequently treated complaints. 
The findings illustrate the range and complexity of chronic disease managed within the homeopathic 
hospitals. The most frequently treated conditions reflect previously published data, with eczema and 
asthma in the top eight along with arthritides, menopausal symptoms, chronic fatigue and breast cancer. 
Research suggests that patients seek out CAM approaches for a number of reasons, including a fear of 
drug side effects and the desire to be more independent in their healthcare. Patients are often appreciative 
of their conventional care but also aware of its limitations.8,  9 Indeed, the medical complaints treated in 
the homeopathic hospitals often reflect areas of clinical practice where available conventional treatments 
are not fully effective – termed “effectiveness gaps”.10
 
The pace and duration of patient care varied considerably between hospitals. This was reflected 
particularly in the differing proportions of patients who received more than 6 appointments. For example, 
one unit, which introduced a 5-appointment package of care in 2001, saw proportionately far fewer 
patients after visit 6 than any other hospital. It is also clear that the scope and complexity of medical 
complaints changed with longer packages of care. In the short-term future, each hospital will need to 
carry out its own additional local audit and introduce a package of care that has more equivalence at a 
national level. Importantly, this pilot has informed the process by which such local audit may proceed 
through the adoption of identical aims and methods. 
 
The average ORIDL Profile Score of +1.81 or more that was achieved in patients who were attending at 
least their fourth homeopathic appointment indicates that a meaningful improvement in health (OPS > 
+2)7 was gained in many cases [?need to specify precise number/proportion in Results?]. The large s.d. 
values around this average indicate considerable variability of individual response to treatment. The 
magnitude and degree of change was clearly dependent on the main presenting complaint, with chronic 
 
 
fatigue patients showing less change over the period of care than eczema patients, for example. It is 
information of this kind that will be used in our medium-term aim of setting standards for clinical 
outcomes associated with homeopathic treatment in patients with given medical complaints. There is 
clearly a need to track individual patients over time, and this will be a key feature of the ongoing 
development programme. This process will also necessarily take into account severity of presenting 
symptoms and the presence of any important co-morbidity. Again, a unified approach will be taken to 
clinical data collection across all hospitals at that stage. The ultimate objective of the initiative – to 
establish national benchmarks for homeopathic practice outcomes in the hospital outpatient setting – will 
then be enabled. Benchmarking is “a process of comparing, sharing and developing practice in order to 
achieve and sustain best practice”.11, , 12 13
 
This 4-week national cross section of homeopathic outcomes data supports previous reports that referral 
to homeopathic hospital outpatients is often associated with valuable improvement in patients’ health, 
and for a wide variety and complexity of medical complaints. Although these data are suggestive that 
patients staying within the system gain improvements both in presenting complaint and wellbeing, we 
cannot conclude that these are due to homeopathy specifically. By definition, a study of this nature 
involves no reference group of patients to serve as controls. Moreover, we are unable to take into account 
other factors, such as improvement of symptoms that may have happened spontaneously over time (as in 
menopausal disorder), or where conventional treatments might have had an important impact during the 
package of care (as in asthma, for example). In addition, it should be noted that these data only reflect 
changes in the patient sample that stayed in the system. Those patients who did not attend (DNA) may 
have improved to their satisfaction or found homeopathy unhelpful. In subsequent studies, full account 
will be taken of DNA patients, together with those who use other CAM and/or conventional medicines. 
Our pilot findings are thus informing the next stage of data collection, aiming to set and sustain the 
highest appropriate standards of clinical outcomes that can be expected from homeopathic treatment 
patients with given medical complaints. 
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Appendix A 
 
Outcome Related to Impact on Daily Living (ORIDL) 
 
 
Ask every follow-up patient: 
 
1.  Compared to how you were before your initial appointment, what has been the overall 
effect of your treatment at this hospital on your Main Complaint (the one you came to get 
treated)? 
 
If the patient says “none”, “the same” or is unsure, record 0. 
 
If the patient says “better” or “worse”, record their perceived degree of improvement or 
deterioration based on the numerical scale below. 
 
2.  Compared to how you were before your initial appointment, what has been the overall 
effect of your treatment at this hospital on your general Well-being? 
 
If the patient says “none”, “no change” or is unsure, record 0. 
 
If the patient says “better” or “worse”, record their perceived degree of improvement or 
deterioration based on the numerical scale below. 
 
  +4     Cured / Back to normal 
  +3     Major Improvement 
  +2     Moderate improvement, affecting daily living 
  +1     Slight improvement, no effect on daily living 
     0     No change / Unsure 
  -1     Slight deterioration, no effect on daily living 
   -2     Moderate deterioration, affecting daily living 
  -3     Major deterioration 
  -4     Disastrous deterioration 
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